Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
Status:
Recruiting
Trial end date:
2027-01-25
Target enrollment:
Participant gender:
Summary
This is a multicenter hospital-based prospective cohort study conducted in institutions with
known expertise in performing oocytes/embryo freezing for fertility preservation. The study
aims at refining the understanding of the efficacy and safety of controlled ovarian
stimulation with or without letrozole in young women with newly diagnosed breast cancer who
are candidates to receive (neo)adjuvant chemotherapy.